SEC Form 4 · accession 0000899243-18-005026
Calithera Biosciences, Inc. · CALA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Francesco Parlati
Officer — VP, RESEARCH
Period of report
Feb 20, 2018
Accepted (ET)
Feb 22, 2018 · 4:05 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001496671
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 20, 2018 | M | 1,979 | $0.96 | A | 17,372 | D | |
| Common StockF1 | Feb 20, 2018 | M | 3,116 | $0.96 | A | 20,488 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F2 | $0.96 | Feb 20, 2018 | M | 1,979 | D | — | May 22, 2023 | Common Stock | 1,979 | 0 | D |
| Employee Stock Option (Right to Buy)F3 | $0.96 | Feb 20, 2018 | M | 3,116 | D | — | May 22, 2023 | Common Stock | 3,116 | 0 | D |
Explanation of responses
- F1Includes 973 and 2,038 shares acquired under the Company's 2014 Employee Stock Purchase Plan on June 9, 2017 and December 8, 2017, respectively.
- F21/48th of the Option vests in equal monthly installments beginning November 15, 2012. The Option shall be subject to accelerated vesting as set forth in the optionee's employment agreement with the Company.
- F31/48th of the Option vests in equal monthly installments one month after May 23, 2013. The Option shall be subject to accelerated vesting as set forth in the optionee's employment agreement with the Company.